Hoefflin, R.; Harlander, S.; Abhari, B.A.; Peighambari, A.; Adlesic, M.; Seidel, P.; Zodel, K.; Haug, S.; Göcmen, B.; Li, Y.;
et al. Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma. Cancers 2021, 13, 4801.
https://doi.org/10.3390/cancers13194801
AMA Style
Hoefflin R, Harlander S, Abhari BA, Peighambari A, Adlesic M, Seidel P, Zodel K, Haug S, Göcmen B, Li Y,
et al. Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma. Cancers. 2021; 13(19):4801.
https://doi.org/10.3390/cancers13194801
Chicago/Turabian Style
Hoefflin, Rouven, Sabine Harlander, Behnaz A. Abhari, Asin Peighambari, Mojca Adlesic, Philipp Seidel, Kyra Zodel, Stefan Haug, Burulca Göcmen, Yong Li,
and et al. 2021. "Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma" Cancers 13, no. 19: 4801.
https://doi.org/10.3390/cancers13194801
APA Style
Hoefflin, R., Harlander, S., Abhari, B. A., Peighambari, A., Adlesic, M., Seidel, P., Zodel, K., Haug, S., Göcmen, B., Li, Y., Lahrmann, B., Grabe, N., Heide, D., Boerries, M., Köttgen, A., Heikenwalder, M., & Frew, I. J.
(2021). Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma. Cancers, 13(19), 4801.
https://doi.org/10.3390/cancers13194801
